UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis

Annals of oncology, 2015-07, Vol.26 (7), p.1305-1313

2015

Volltextzugriff (PDF)

Primary lymphoma of the female genital tract: a retrospective survey of the International Extranodal Lymphoma Study Group (IELSG35)

Hematological oncology, 2023-06, Vol.41 (S2), p.412-413

2023

Volltextzugriff (PDF)

A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA—OUTCOMES INDICATIVE FOR IMPROVED SURVIVAL OVERTIME

Hematological oncology, 2023-06, Vol.41 (S2), p.692-693

2023

Volltextzugriff (PDF)

FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Non-Hodgkin's lymphoma in patients 80 years of age or older

Annals of oncology, 2006-06, Vol.17 (6), p.928-934

2006

Volltextzugriff (PDF)

FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.103-104

2019

Volltextzugriff (PDF)

PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: AN UPDATE WITH DATA FROM 181 PATIENTS

Hematological oncology, 2019-06, Vol.37 (S2), p.255-256

2019

Volltextzugriff (PDF)

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells

Leukemia research, 2004-03, Vol.28 (3), p.243-248

2004

Volltextzugriff (PDF)

Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells

International journal of laboratory hematology, 2010-02, Vol.32 (1p1), p.e77-e85

2010

Volltextzugriff (PDF)

CURRENT THERAPY OF SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: DATA FROM A MULTICENTER PROSPECTIVE INTERNATIONAL REGISTRY

Hematological oncology, 2017-06, Vol.35 (S2), p.196-197

2017

Volltextzugriff (PDF)

Bcl‐2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

British journal of haematology, 2001-05, Vol.113 (2), p.400-406

2001

Volltextzugriff (PDF)

P11.67.B A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - OUTCOMES INDICATIVE OF IMPROVED SURVIVAL OVER TIME

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii90-ii90

2023

Volltextzugriff (PDF)

P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii34-iii34

2019

Volltextzugriff (PDF)

Serum CA 125 levels in patients with chronic lymphocytic leukemia

Clinical and laboratory haematology, 2005-02, Vol.27 (1), p.57-60

2005

Volltextzugriff (PDF)

Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas

Medical oncology (Northwood, London, England), 2000, Vol.17 (4), p.314-318

2000

Volltextzugriff (PDF)

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma

British journal of cancer, 2002-06, Vol.86 (11), p.1770-1775

2002

Volltextzugriff (PDF)

Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 2003-01, Vol.44 (10), p.1733-1738

2003

Volltextzugriff (PDF)

Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience

Haematologica (Roma), 2015-05, Vol.100 (5), p.662-669

2015

Volltextzugriff (PDF)

P14.10 Secondary CNS involvement in malignant lymphoma: Data from a multicenter prospective international registry

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii104-iii104

2017

Volltextzugriff (PDF)

Increased Thromboembolic Events After Lung Transplantation

Chest, 2006-02, Vol.129 (2), p.412-416

2006

Volltextzugriff (PDF)

Severe Tissue Necrosis After Cisplatin Extravasation at Low Concentration: Possible “Immediate Recall Phenomenon”

JNCI : Journal of the National Cancer Institute, 1997-08, Vol.89 (16), p.1233-1234

1997

Volltextzugriff (PDF)

Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review

The Journal of heart valve disease, 2001-07, Vol.10 (4), p.431

2001

Volltextzugriff (PDF)

Doxorubicin and a butyric acid derivative effectively reduce levels of BCL‐2 protein in the cells of chronic lymphocytic leukemia patient

European journal of haematology, 2001-04, Vol.66 (4), p.263-271

2001

Volltextzugriff (PDF)

Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease

European journal of haematology, 2000-02, Vol.64 (2), p.80-84

2000

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(91)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(62)
Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Female
(46)
Middle Aged
(37)
Aged
(36)
Male
(30)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Adult
(23)
Aged, 80 And Over
(20)
Hematology
(19)
Cardiovascular System & Cardiology
(18)
Cardiac & Cardiovascular Systems
(17)
Oncology
(15)
Cardiology. Vascular System
(12)
Prognosis
(11)
Hematologic And Hematopoietic Diseases
(10)
Risk Factors
(10)
Follow-Up Studies
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis

Primary lymphoma of the female genital tract: a retrospective survey of the International Extranodal Lymphoma Study Group (IELSG35)

A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA—OUTCOMES INDICATIVE FOR IMPROVED SURVIVAL OVERTIME

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

FIRST‐LINE TREATMENT WITH IBRUTINIB FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): 7‐YEAR RESULTS FROM RESONATE‐2

Non-Hodgkin's lymphoma in patients 80 years of age or older

FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA

PROSPECTIVE MULTICENTER REGISTRY FOR SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: AN UPDATE WITH DATA FROM 181 PATIENTS

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells

Arsenic-trioxide-induced apoptosis of chronic lymphocytic leukemia cells

CURRENT THERAPY OF SECONDARY CNS INVOLVEMENT IN MALIGNANT LYMPHOMA: DATA FROM A MULTICENTER PROSPECTIVE INTERNATIONAL REGISTRY

Bcl‐2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

P11.67.B A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - OUTCOMES INDICATIVE OF IMPROVED SURVIVAL OVER TIME

P05.04 Phase 2 open-label study of maintenance treatment with ibrutinib following first line methotrexate-based immuno-chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)

Serum CA 125 levels in patients with chronic lymphocytic leukemia

Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas

Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma

Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma

Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience

P14.10 Secondary CNS involvement in malignant lymphoma: Data from a multicenter prospective international registry

Increased Thromboembolic Events After Lung Transplantation

Severe Tissue Necrosis After Cisplatin Extravasation at Low Concentration: Possible “Immediate Recall Phenomenon”

Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review

Doxorubicin and a butyric acid derivative effectively reduce levels of BCL‐2 protein in the cells of chronic lymphocytic leukemia patient

Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease

Suchergebnisse filtern